Comparison of a stool antigen test and serology for the diagnosis of helicobacter pylori infection in mass survey

Helicobacter

Volumn 14, Issue 2, 2009, Pages 87-90

  Shimoyama, Tadashi ^a   Oyama, Takao ^a   Matsuzaka, Masashi ^a   Danjo, Kazuma ^a   Nakaji, Shigeyuki ^a   Fukuda, Shinsaku ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Helicobacter pylori; Mass survey; Stool antigen test

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; PEPSINOGEN I; PEPSINOGEN II;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; ATROPHIC GASTRITIS; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME IMMUNOASSAY; FECES ANALYSIS; FEMALE; HEALTH SURVEY; HELICOBACTER INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROLOGY;

AGED; ANTIGENS, BACTERIAL; FECES; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOASSAY; JAPAN; MALE; MASS SCREENING; MIDDLE AGED;

HELICOBACTER PYLORI;

EID: 62149097875     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2009.00672.x     Document Type: Article

References (21)

1. Neugat AI, Hayek H, Howe G. Epidemiology of gastric cancer. Semin Oncol 1996 23 : 281 91.
2. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992 52 : 6735 40.
3. Nardone G, Rocco A, Staibano S, et al. Diagnostic accuracy of the serum profile of gastric mucosa in relation to histological and morphometric diagnosis of atrophy. Aliment Pharmacol Ther 2005 22 : 1139 46.
4. Oishi Y, Kiyohara Y, Kubo M, et al. The serum pepsinogen test as a predictor of gastric cancer. The Hisayama Study. Am J Epidemiol 2006 163 : 629 37.
5. Miki K, Ichinose M, Ishikawa KB, et al. Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer. Jpn J Cancer Res 1993 84 : 1086 90.
6. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001 345 : 784 9.
7. Watabe H, Mitsushima T, Yamaji Y, et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut 2005 54 : 764 8.
8. Gisbert JP, de la Morena F, Abraira V. Accuracy of monoclonal stool antigen test for the diagnosis of H. pylori infection: a systematic review and meta-analysis. Am J Gastroenterol 2006 101 : 1921 30.
9. Tanaka A, Watanabe K, Tokunaga K, et al. Evaluation of Helicobacter pylori stool antigen test before and after eradication therapy. J Gastroenterol Hepatol 2003 18 : 732 8.
10. Suzuki N, Wakasugi M, Nakaya S, et al. Production and application of new monoclonal antibodies specific for a fecal Helicobacter pylori antigen. Clin Diagn Lab Immunol 2002 9 : 75 8.
11. Cardenas VM, Dominguez DC, Puentes FA, et al. Evaluation of a novel stool native catalase antigen test for Helicobacter pylori infection in asymptomatic North American children. J Pediatr Gastroenterol Nutr 2008 46 : 399 402.
12. Miki K, Morita M, Sasajima M, Hoshina R, Kanda E, Urita Y. Usefulness of gastric cancer screening using the serum pepsinogen test method. Am J Gastroenterol 2003 98 : 735 9.
13. Domínguez J, Forné M, Blanco S, et al. Comparison of a monoclonal with a polyclonal antibody-based enzyme immunoassay stool test in diagnosing Helicobacter pylori infection before and after eradication therapy. Aliment Pharmacol Ther 2006 23 : 1735 40.
14. Tokunaga K, Tanaka A, Takahashi S. Evaluation of diagnostic method for Helicobacter pylori infection. Nippon Rinsho 2005 63 : 403 8. [in Japanese].
15. Elwyn G, Taubert M, Davies S, Brown G, Allison M, Phillips C. Which test is best for Helicobacter pylori? A cost-effectiveness model using decision analysis. Br J Gen Pract 2007 57 : 401 3.
16. Fukuda Y, Tomita T, Hori K, Sakagami T, Sakaedani N, Shimoyama T. Evaluation of a novel Helicobacter stool antigen detection kit, Testmate rapid pylori antigen, for rapid diagnosis of Helicobacter pylori infection. Igaku Yakugaku 2004 52 : 469 74. [in Japanese]
17. Nomura AM, Kolonel LN, Miki K, et al. Helicobacter pylori, pepsinogen, and gastric adenocarcinoma in Hawaii. J Infect Dis 2005 191 : 2075 81.
18. Kokkola A, Louhimo J, Puolakkainen P, Alfthan H, Haglund C, Rautelin H. Helicobacter pylori infection and low serum pepsinogen I level as risk factors for gastric carcinoma. World J Gastroenterol 2005 11 : 1032 6.
19. Kato M, Asaka M, Nakamura T, et al. Helicobacter pylori eradication prevents the development of gastric cancer - results of a long-term retrospective study in Japan. Aliment Pharmacol Ther 2006 24 : 203 6.
20. Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008 372 : 392 7.
21. Tanaka A, Watari J, Tanabe H, et al. Effect of eradication of Helicobacter pylori on genetic instabilities in gastric intestinal metaplasia. Aliment Pharmacol Ther 2006 24 : 194 202.